Jaw Osteonecrosis Associated with Use of Bisphosphonates and Chemotherapy: Paradoxical Complication of Treatment of Bone Lesions in Multiple Myeloma Patients

被引：0

作者：

Silvana Capalbo

Mario Delia

Daniela Diomede

Michelina Dargenio

Antonia Chiefa

Gianfranco Favia

Vincenzo Liso

机构：

[1] University of Bari Policlinico,Hematology Section, Department of Internal Medicine and Public Medicine

[2] University of Bari Policlinico,Department of Dental Science and Surgery

来源：

International Journal of Hematology | 2006年 / 83卷

关键词：

Bisphosphonates; Osteonecrosis; Jaw bones; Multiple myeloma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

It has been demonstrated that bisphosphonate-based supportive therapy (pamidronate or zoledronate) reduces skeletal events (onset or progression of osteolytic lesions) both in patients with multiple myeloma (MM) and in cancer patients with bone metastasis. Bisphosphonates (eg, alendronate) are also indicated in the treatment of osteoporosis. Nevertheless, osteonecrosis of the jaw (ONJ) has been reported in some patients being treated with bisphosphonates. We present a series of 9 MM patients who developed ONJ after treatment with bisphosphonates and chemotherapy. All the patients in this case series had undergone tooth extraction for recurrent dental abscesses while taking bisphosphonates. We also review the diagnostic and therapeutic implications of this paradoxical complication associated with treatment of bone lesions in MM.

引用

页码：439 / 442

页数：3

共 50 条

[31] Correlating the Prevalence of bisphosphonate-associated Osteonecrosis of the Jaw with the Duration of Onset of Bisphosphonates in Tumor and Osteoporosis Patients? Overall Evaluation of the German Osteonecrosis of the Jaw Registry [J].

Karberg, Niels ;

Felsenberg, Dieter .

JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2020, 27 (01) :8-18

[32] Use of bisphosphonates in multiple myeloma patients in Denmark, 2005–2015 [J].

Tina Bech Olesen ;

Ina Trolle Andersen ;

Anne Gulbech Ording ;

Vera Ehrenstein ;

Anouchka Seesaghur ;

Carsten Helleberg ;

Trine Silkjær ;

Rohini K. Hernandez ;

Daniela Niepel ;

Niels Abildgaard .

Supportive Care in Cancer, 2021, 29 :4501-4511

[33] Osteonecrosis of the jaw associated with the use of Bisphosphonates. Part I: Etiology and Clinical Presentation [J].

Coelho, Ana Isabel ;

Gomes, Pedro de Sousa ;

Fernandes, Maria Helena .

REVISTA PORTUGUESA DE ESTOMATOLOGIA MEDICINA DENTARIA E CIRURGIA MAXILOFACIAL, 2010, 51 (02) :95-101

[34] Clinical aspects of bisphosphonate-associated oral osteonecrosis in patients with multiple myeloma [J].

Gaglioti, Domenico ;

Andriani, Alessandro ;

Colasanti, Ubalbo ;

Papa, Raffaele ;

Villiva, Nicoletta ;

Riva, Chiara .

CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2006, 3 (02) :192-197

[35] PLATELET-RICH PLASMA IMPROVES WOUND HEALING IN MULTIPLE MYELOMA BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW PATIENTS [J].

Coviello, V. ;

Peluso, F. ;

Dehkhargani, S. Z. ;

Verdugo, F. ;

Raffaelli, L. ;

Manicone, P. F. ;

D'Addona, A. .

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2012, 26 (01) :151-155

[36] Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients [J].

Christian Walter ;

Bilal Al-Nawas ;

Norbert Frickhofen ;

Heinold Gamm ;

Joachim Beck ;

Laura Reinsch ;

Christina Blum ;

Knut A. Grötz ;

Wilfried Wagner .

Head & Face Medicine, 6

[37] Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma [J].

Brantus, J. -F. ;

Roemer-Becuwe, C. ;

Cony-Makhoul, P. ;

Salino, S. ;

Fontana, A. ;

Debourdea, P. ;

Thomas, T. ;

Guastalla, J. -P. ;

Ghesquieres, H. ;

Sebban, C. ;

Pavic, M. ;

Collet, P. ;

Larbre, J. -P. ;

Martinon, S. ;

Brocard, F. ;

Bodard, A. -G. ;

Blanc, G. ;

Balestriere, V. ;

Favier, B. ;

Farsi, F. ;

Krakowski, I. ;

Biron, P. .

REVUE DE MEDECINE INTERNE, 2011, 32 (08) :494-505

[38] Immunohistochemial evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw [J].

Siniscalchi, Enrico Nastro ;

Cutroneo, Giuseppina ;

Catalfamo, Luciano ;

Santoro, Giuseppe ;

Allegra, Alessandro ;

Oteri, Giacomo ;

Cicciu, Domenico ;

Alonci, Andrea ;

Penna, Giuseppa ;

Musolino, Caterina ;

De Ponte, Francesco Saverio ;

Anastasi, Giuseppe ;

Favaloro, Angelo .

ONCOLOGY REPORTS, 2010, 24 (01) :129-134

[39] Bisphosphonates Induce Apoptosis of Circulating Endothelial Cells in Multiple Myeloma Patients and in Subjects with Bisphosphonate-Induced Osteonecrosis of the Jaws [J].

Allegra, Alessandro ;

Alonci, Andrea ;

Penna, Giuseppa ;

Granata, Angela ;

Siniscalchi, Enrico Nastro ;

Oteri, Giacomo ;

Loddo, Saverio ;

Teti, Diana ;

Ciccu, Domenico ;

De Ponte, Francesco Saverio ;

Musolino, Caterina .

ACTA HAEMATOLOGICA, 2010, 124 (02) :79-85

[40] Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients [J].

Gabbert, Tatjana I. ;

Hoffmeister, Bodo ;

Felsenberg, Dieter .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (04) :749-758

← 1 2 3 4 5 →